OPX Biotechnologies Lands $36,500,000 Series C Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7351be3-8173-4d49-8426-843b0dc6f9b6&Preview=1 - Date
7/7/2011 - Company Name
OPX Biotechnologies - Mailing Address
2425 55th Street Boulder, CO 80301 - Company Description
OPX Biotechnologies, Inc. is a new company dedicated to enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products. We are using a pioneering technology platform known as SCALEs to enable massively parallel full genome search and modification to rapidly optimize the microbes used for producing biofuels and biorefined chemicals. Our goal is to vastly decrease production costs and capital requirements, thus removing one of the major barriers to the use of renewable fuels and chemicals. - Website
http://www.opxbiotechnologies.com - Transaction Type
Venture Equity - Transaction Amount
$36,500,000 - Transaction Round
Series C - Proceeds Purposes
The new investment will enable OPXBIO to accelerate development and commercialization of an industrial-scale process for producing its first renewable chemical, BioAcrylic. - M&A Terms
- Venture Investor
US Renewables Group - Venture Investor
DBL Investors - Venture Investor
Mohr Davidow Ventures - Venture Investor
Braemar Energy Ventures - Venture Investor
Altira Group - Venture Investor
X/Seed Capital
